Asthma drug under ‘review’ after surge in psychiatric incidents

The medicines watchdog is finalising a review of asthma drug montelukast after a rise in Yellow Card reports, amid a shortage of other asthma drugs. 

montelukast
The drug can cause “hallucinations and suicidal behavior”
Kate Bowie

Read more by Kate Bowie

Kate Bowie joined C+D as a digital reporter in August 2023 after graduating from a master’s in journalism at City, University of London. She began covering the primary care beat at the end of 2022, when she carried out several health investigations focused on staffing issues, NHS funding and health inequalities.

Latest from News

More from Clinical